iBio
IBIO
IBIO
21 hedge funds and large institutions have $345K invested in iBio in 2023 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 7 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
19% less funds holding
Funds holding: 26 → 21 (-5)
50% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 10
Holders
21
Holding in Top 10
–
Calls
$193K
Puts
$2K
Top Buyers
| 1 | +$242K | |
| 2 | +$34.8K | |
| 3 | +$26.2K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$23.2K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$6.55K |
Top Sellers
| 1 | -$76.2K | |
| 2 | -$47K | |
| 3 | -$34.2K | |
| 4 |
HF
HRT Financial
New York
|
-$19K |
| 5 |
State Street
Boston,
Massachusetts
|
-$14.6K |